Computational Software Assisted Multiple Therapeutic Targets Oriented Screening of Some Natural Alkaloid Compounds

Authors

  • TOMY MURINGAYIL JOSEPH Polymers Technology Department, Faculty of Chemistry, Gdansk University of Technology, 11/12 G. Narutowicza St. 80-233 Gdańsk, Poland
  • DEBARSHI KAR MAHAPATRA Department of Pharmaceutical Chemistry, Dadasaheb Balpande College of Pharmacy, Nagpur 440037, Maharashtra, India

Keywords:

Alkaloid, Molecular docking, In silico, Therapeutic target, Multi-targeted, Inhibitors

Abstract

The current efforts endeavor towards the computational exploration of some interesting
pharmacological potentials of some natural alkaloids by using the Schrodinger Maestro 9.1
software. The excellence in therapeutics was screened against five most imperative targets:
Cyclin-Dependent Kinase-5 (anti-cancer), Cycloxygenase-2 (anti-inflammatory), Protein
kinase C (anti-cancer), Dipeptidyl peptidase (anti-diabetic), and Angiotensin-1-Converting
Enzyme (anti-hypertensive). The alkaloids which were previously reported to possess
antibiotic activities against Bacillus subtilis, Staphylococcus aureus, and Mycobacterium
smegmatis and anti-photo-oxidative, have now perceived to be multi-dimensional compounds
with better pharmacodynamics expression. From the obtained impressive Glide score for the
compounds against the biological target and the dock poses featuring the formation of strong
hydrogen bonding, π-π interactions, and Van der Waals forces through -NH and -OH groups
with several amino acid residues, eventually concluded anti-cancer, anti-diabetic, and antiinflammatory
activities in newer contexts. A new angle of therapeutic excellence can be
noticed from this validated computational study which in larger context rejuvenates and opens
better perspectives for researchers, academicians, and modern scientists towards the
development of dual inhibitors in future. The study explored new applications of various
natural products and has recently developed a perception towards the development of multitargeted
ligands that are not restricted to only one therapeutic response.
Keywords: Alkaloid, molecular docking, in silico, therapeutic target, multi-targeted, inhibitors

Author Biographies

  • TOMY MURINGAYIL JOSEPH, Polymers Technology Department, Faculty of Chemistry, Gdansk University of Technology, 11/12 G. Narutowicza St. 80-233 Gdańsk, Poland

    Polymers Technology Department, Faculty of Chemistry, Gdansk University of Technology, 11/12 G. Narutowicza  St. 80-233 Gdańsk, Poland

  • DEBARSHI KAR MAHAPATRA, Department of Pharmaceutical Chemistry, Dadasaheb Balpande College of Pharmacy, Nagpur 440037, Maharashtra, India

    Debarshi Kar Mahapatra, PhD

    Assistant Professor,

    Department of Pharmaceutical Chemistry,

    Dadasaheb Balpande College of Pharmacy,

    Nagpur 440037, Maharashtra, India

References

Mahapatra DK, Bharti SK, Asati V. Chalcone derivatives: Anti-inflammatory potential and molecular targets perspectives. Curr Top Med Chem. 2017;17(28):3146–69p.

Chhajed SS, Bastikar V, Bastikar AV, Mahapatra DK. Computer Aided Drug Design, 1st Edn. Pune: Everest Publishing House; 2019.

Mahapatra DK, Bharti SK, editors. Pharmacological Perspectives of Low Molecular Weight Ligands, 1st Edn. New Jersey: Apple Academic Press; 2019.

Chhajed SS, Upasani C, Wadher SJ, Mahapatra DK. Medicinal Chemistry, 1st Edn. Nashik: Career Publications Private Limited; 2017.

Mahapatra DK, Bharti SK. Drug Design, 1st Edn. New Delhi, India: Tara Publications Private Limited; 2016.

Mahapatra DK, Bharti SK. Handbook of Research on Medicinal Chemistry: Innovations and Methodologies, 1st Edn. New Jersey: Apple Academic Press; 2017.

Mahapatra DK, Bharti SK. Medicinal Chemistry with Pharmaceutical Product Development, 1st Edn. New Jersey: Apple Academic Press; 2019.

Joseph TM, Mahapatra DK. Bacterial DNA Gyrase (Topoisomerase) Inhibitory Potentials of Heterocyclic Natural Products: Investigations through Induced-Fit Molecular Docking Approach. Res Rev J Drug Des Discov. 2018;5(2):7-9p.

Joseph TM, Mahapatra DK. Induced-Fit Molecular Docking and Pharmacokinetic Prediction Studies of Two Phenanthrene Compound Series as Potential Cyclooxygenase-2 (COX-2) and Lipoxygenase (LOX) Inhibitors: Edema Reducing Prospects of the Emerging Candidates. Res Rev Journal Bioinformat. 2018;5(3):1-8p.

Joseph TM, Mahapatra DK. A Nascent Step towards the Discovery of New Generation Non-Steroidal Anti-inflammatory Agents (NSAIDs): Induced-Fit Molecular Docking and Pharmacokinetic Prediction Studies of Some Chromene Derivatives as Potential Cyclooxygenase-2 (COX-2) and Lipoxygenase (LOX) Inhibitors. Res Rev J Boinformat. 2018;5(2):30-36p.

Downloads

Published

2019-08-14

Issue

Vol. 8 No. 2 (2019)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.